BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patel CD, Backes IM, Taylor SA, Jiang Y, Marchant A, Pesola JM, Coen DM, Knipe DM, Ackerman ME, Leib DA. Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity. Sci Transl Med 2019;11:eaau6039. [PMID: 30971454 DOI: 10.1126/scitranslmed.aau6039] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Le-Trilling VTK, Jagnjić A, Brizić I, Eilbrecht M, Wohlgemuth K, Rožmanić C, Herdman A, Hoffmann K, Westendorf AM, Hengel H, Jonjić S, Trilling M. Maternal antibodies induced by a live attenuated vaccine protect neonatal mice from cytomegalovirus. NPJ Vaccines 2023;8:8. [PMID: 36737485 DOI: 10.1038/s41541-023-00602-4] [Reference Citation Analysis]
2 Jelínková L, Roberts B, Ajayi DT, Peabody DS, Chackerian B. The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice. Biomolecules 2023;13. [PMID: 36830571 DOI: 10.3390/biom13020202] [Reference Citation Analysis]
3 Elste J, Chan A, Patil C, Tripathi V, Shadrack DM, Jaishankar D, Hawkey A, Mungerson MS, Shukla D, Tiwari V. Archaic connectivity between the sulfated heparan sulfate and the herpesviruses - An evolutionary potential for cross-species interactions. Comput Struct Biotechnol J 2023;21:1030-40. [PMID: 36733705 DOI: 10.1016/j.csbj.2023.01.005] [Reference Citation Analysis]
4 Backes IM, Byrd BK, Slein MD, Patel CD, Taylor SA, Garland CR, MacDonald SW, Balazs AB, Davis SC, Ackerman ME, Leib DA. Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidity. J Exp Med 2022;219. [PMID: 36156707 DOI: 10.1084/jem.20220110] [Reference Citation Analysis]
5 Backes IM, Leib DA, Ackerman ME. Monoclonal antibody therapy of herpes simplex virus: An opportunity to decrease congenital and perinatal infections. Front Immunol 2022;13:959603. [DOI: 10.3389/fimmu.2022.959603] [Reference Citation Analysis]
6 Zhang H, Li Z, Li C, Chen R, Liu T, Jiang Y. Antiviral Effect of Polyphenolic Substances in Geranium wilfordii Maxim against HSV-2 Infection Using in vitro and in silico Approaches. Evid Based Complement Alternat Med 2022;2022:7953728. [PMID: 35646147 DOI: 10.1155/2022/7953728] [Reference Citation Analysis]
7 Chandrasekar V, Singh AV, Maharjan RS, Dakua SP, Balakrishnan S, Dash S, Laux P, Luch A, Singh S, Pradhan M. Perspectives on the Technological Aspects and Biomedical Applications of Virus‐Like Particles/Nanoparticles in Reproductive Biology: Insights on the Medicinal and Toxicological Outlook. Advanced NanoBiomed Research. [DOI: 10.1002/anbr.202200010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Goswami R, Pavon CG, Miller IG, Berendam SJ, Williams CA, Rosenthal D, Gross M, Phan C, Byrd A, Pollara J, Permar SR, Fouda GG. Prenatal Immunization to Prevent Viral Disease Outcomes During Pregnancy and Early Life. Front Virol 2022;2. [DOI: 10.3389/fviro.2022.849995] [Reference Citation Analysis]
9 Awasthi S, Friedman HM. An mRNA vaccine to prevent genital herpes. Transl Res 2022;242:56-65. [PMID: 34954087 DOI: 10.1016/j.trsl.2021.12.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
10 Backes IM, Byrd BK, Patel CD, Taylor SA, Garland CR, Macdonald SW, Balazs AB, Davis SC, Ackerman ME, Leib DA. Maternally transferred monoclonal antibodies protect neonatal mice from herpes simplex virus-induced mortality and morbidity.. [DOI: 10.1101/2022.01.12.476098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kim T, Azar DT, Pavan-langston D. Viral Disease of the Cornea and External Eye. Albert and Jakobiec's Principles and Practice of Ophthalmology 2022. [DOI: 10.1007/978-3-030-42634-7_209] [Reference Citation Analysis]
12 de Paiva CS, St Leger AJ, Caspi RR. Mucosal immunology of the ocular surface. Mucosal Immunol 2022;15:1143-57. [PMID: 36002743 DOI: 10.1038/s41385-022-00551-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Price NB, Wood KE. Distinguishing Features Common to Dual Fatal Herpes Simplex Virus Infections That Occur in Both a Pregnant Woman and Her Newborn Infant. Viruses 2021;13:2542. [PMID: 34960811 DOI: 10.3390/v13122542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 St Leger AJ, Koelle DM, Kinchington PR, Verjans GMGM. Local Immune Control of Latent Herpes Simplex Virus Type 1 in Ganglia of Mice and Man. Front Immunol 2021;12:723809. [PMID: 34603296 DOI: 10.3389/fimmu.2021.723809] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Stanfield BA, Kousoulas KG, Fernandez A, Gershburg E. Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses. Viruses 2021;13:1637. [PMID: 34452501 DOI: 10.3390/v13081637] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
16 Kushch AA, Kisteneva LB, Klimova RR, Cheshik SG. [The role of herpesviruses in development of diseases of the urogenital tract and infertility in women]. Vopr Virusol 2021;65:317-25. [PMID: 33533228 DOI: 10.36233/0507-4088-2020-65-6-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Kao CM, Goymer J, Loh LN, Mahant A, Burn Aschner C, Herold BC. Murine Model of Maternal Immunization Demonstrates Protective Role for Antibodies That Mediate Antibody-Dependent Cellular Cytotoxicity in Protecting Neonates From Herpes Simplex Virus Type 1 and Type 2. J Infect Dis 2020;221:729-38. [PMID: 31599942 DOI: 10.1093/infdis/jiz521] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
18 LaTourette PC 2nd, Awasthi S, Desmond A, Pardi N, Cohen GH, Weissman D, Friedman HM. Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine. Vaccine 2020;38:7409-13. [PMID: 33041105 DOI: 10.1016/j.vaccine.2020.09.079] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
19 Vygivska LA, Rudenko LA, Kalnytska VB, Litvinenko OY. FEATURES OF THE COURSE OF PERINATAL INFECTIONS AT THE PRESENT STAGE. Wiad Lek 2020;73:2269-2276. [DOI: 10.36740/wlek202010132] [Reference Citation Analysis]
20 Silke Heilingloh C, Lull C, Kleiser E, Alt M, Schipper L, Witzke O, Trilling M, Eis-Hübinger AM, Dittmer U, Krawczyk A. Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1. Vaccines (Basel) 2020;8:E478. [PMID: 32867086 DOI: 10.3390/vaccines8030478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Macedo-da-Silva J, Marinho CRF, Palmisano G, Rosa-Fernandes L. Lights and Shadows of TORCH Infection Proteomics. Genes (Basel) 2020;11:E894. [PMID: 32764347 DOI: 10.3390/genes11080894] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
22 Egan KP, Hook LM, Naughton A, Pardi N, Awasthi S, Cohen GH, Weissman D, Friedman HM. An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection. PLoS Pathog 2020;16:e1008795. [PMID: 32716975 DOI: 10.1371/journal.ppat.1008795] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
23 Giraldo D, Wilcox DR, Longnecker R. The Innate Immune Response to Herpes Simplex Virus 1 Infection Is Dampened in the Newborn Brain and Can Be Modulated by Exogenous Interferon Beta To Improve Survival. mBio 2020;11:e00921-20. [PMID: 32457247 DOI: 10.1128/mBio.00921-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
24 Patel CD, Taylor SA, Mehrbach J, Awasthi S, Friedman HM, Leib DA. Trivalent Glycoprotein Subunit Vaccine Prevents Neonatal Herpes Simplex Virus Mortality and Morbidity. J Virol 2020;94:e02163-19. [PMID: 32188735 DOI: 10.1128/JVI.02163-19] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
25 Chu TH, Crowley AR, Backes I, Chang C, Tay M, Broge T, Tuyishime M, Ferrari G, Seaman MS, Richardson SI, Tomaras GD, Alter G, Leib D, Ackerman ME. Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies. PLoS Pathog 2020;16:e1008083. [PMID: 32092122 DOI: 10.1371/journal.ppat.1008083] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
26 Saso A, Kampmann B. Maternal Immunization: Nature Meets Nurture. Front Microbiol 2020;11:1499. [PMID: 32849319 DOI: 10.3389/fmicb.2020.01499] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 6.7] [Reference Citation Analysis]
27 Chu HY, Marchant A. Immunobiological aspects of vaccines in pregnancy: Maternal perspective. Maternal Immunization 2020. [DOI: 10.1016/b978-0-12-814582-1.00003-6] [Reference Citation Analysis]
28 Akhtar LN, Szpara ML. Viral genetic diversity and its potential contributions to the development and progression of neonatal herpes simplex virus (HSV) disease. Curr Clin Microbiol Rep 2019;6:249-56. [PMID: 32944492 DOI: 10.1007/s40588-019-00131-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Hassan M, Netchiporouk E, Litvinov IV. New dl5-29-Attenuated Replication-Deficient HSV Vaccine Provides a Ray of Hope for the Prevention of Neonatal HSV Infection. J Cutan Med Surg 2019;23:554-5. [PMID: 31478773 DOI: 10.1177/1203475419860506] [Reference Citation Analysis]